ITMC Stock Overview
Engages in the processing, production, and distribution of medical cannabis products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Itoco Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.005 |
| 52 Week High | US$0.04 |
| 52 Week Low | US$0.003 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -58.33% |
| 3 Year Change | -97.06% |
| 5 Year Change | -98.44% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ITMC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 1.7% |
| 1Y | -58.3% | 14.9% | 26.0% |
Return vs Industry: ITMC underperformed the US Pharmaceuticals industry which returned 14.9% over the past year.
Return vs Market: ITMC underperformed the US Market which returned 26% over the past year.
Price Volatility
| ITMC volatility | |
|---|---|
| ITMC Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ITMC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ITMC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Gilbert Paez | www.itoco.net |
Itoco Inc. engages in the processing, production, and distribution of medical cannabis products. The company was formerly known as Itoco Mining Corporation and changed its name to Itoco Inc. in May 2018. Itoco Inc. is based in Reno, Nevada.
Itoco Inc. Fundamentals Summary
| ITMC fundamental statistics | |
|---|---|
| Market cap | US$2.14m |
| Earnings (TTM) | -US$2.26k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ITMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ITMC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$2.26k |
| Earnings | -US$2.26k |
Last Reported Earnings
Dec 31, 2013
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ITMC perform over the long term?
See historical performance and comparison